BIOLASE (BIOL) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

BIOLASE Revenue Highlights


Latest Revenue (Y)

$49.16M

Latest Revenue (Q)

$11.55M

Main Segment (Y)

Laser Systems

Main Geography (Y)

UNITED STATES

BIOLASE Revenue by Period


BIOLASE Revenue by Year

DateRevenueChange
2023-12-31$49.16M1.45%
2022-12-31$48.46M23.67%
2021-12-31$39.19M72.03%
2020-12-31$22.78M-39.73%
2019-12-31$37.80M-18.10%
2018-12-31$46.16M-1.64%
2017-12-31$46.93M-9.43%
2016-12-31$51.81M6.88%
2015-12-31$48.48M1.72%
2014-12-31$47.66M-15.55%
2013-12-31$56.43M-1.61%
2012-12-31$57.36M17.39%
2011-12-31$48.86M86.30%
2010-12-31$26.23M-39.50%
2009-12-31$43.35M-32.93%
2008-12-31$64.63M-3.38%
2007-12-31$66.89M-4.03%
2006-12-31$69.70M12.46%
2005-12-31$61.98M2.19%
2004-12-31$60.65M23.57%
2003-12-31$49.08M68.09%
2002-12-31$29.20M63.24%
2001-12-31$17.89M85.22%
2000-12-31$9.66M37.88%
1999-12-31$7.00M366.95%
1998-12-31$1.50M-16.67%
1997-12-31$1.80M157.14%
1996-12-31$700.00K-41.67%
1995-12-31$1.20M9.09%
1994-12-31$1.10M-54.17%
1993-12-31$2.40M-

BIOLASE generated $49.16M in revenue during NA 2023, up 1.45% compared to the previous quarter, and up 106.52% compared to the same period a year ago.

BIOLASE Revenue by Quarter

DateRevenueChange
2024-06-30$11.55M14.06%
2024-03-31$10.13M-24.90%
2023-12-31$13.49M23.52%
2023-09-30$10.92M-23.55%
2023-06-30$14.29M36.49%
2023-03-31$10.47M-25.51%
2022-12-31$14.05M16.99%
2022-09-30$12.01M-1.84%
2022-06-30$12.23M20.35%
2022-03-31$10.17M-18.06%
2021-12-31$12.41M30.18%
2021-09-30$9.53M4.35%
2021-06-30$9.13M12.54%
2021-03-31$8.12M-4.74%
2020-12-31$8.52M30.30%
2020-09-30$6.54M122.57%
2020-06-30$2.94M-38.57%
2020-03-31$4.78M-53.02%
2019-12-31$10.18M17.77%
2019-09-30$8.65M0.01%
2019-06-30$8.64M-16.28%
2019-03-31$10.33M-20.84%
2018-12-31$13.04M19.28%
2018-09-30$10.94M-10.02%
2018-06-30$12.15M21.30%
2018-03-31$10.02M-20.69%
2017-12-31$12.63M16.92%
2017-09-30$10.81M-14.32%
2017-06-30$12.61M15.98%
2017-03-31$10.87M-20.98%
2016-12-31$13.76M4.02%
2016-09-30$13.23M-4.21%
2016-06-30$13.81M25.43%
2016-03-31$11.01M-24.16%
2015-12-31$14.52M29.22%
2015-09-30$11.23M-5.35%
2015-06-30$11.87M9.34%
2015-03-31$10.86M-18.00%
2014-12-31$13.24M4.12%
2014-09-30$12.71M24.82%
2014-06-30$10.19M-11.56%
2014-03-31$11.52M-24.43%
2013-12-31$15.24M23.46%
2013-09-30$12.35M-13.35%
2013-06-30$14.25M-2.40%
2013-03-31$14.60M-23.50%
2012-12-31$19.08M38.45%
2012-09-30$13.78M3.49%
2012-06-30$13.32M8.08%
2012-03-31$12.32M-6.36%
2011-12-31$13.16M0.74%
2011-09-30$13.06M8.13%
2011-06-30$12.08M14.37%
2011-03-31$10.56M8.67%
2010-12-31$9.72M56.24%
2010-09-30$6.22M5.57%
2010-06-30$5.89M34.06%
2010-03-31$4.39M-57.54%
2009-12-31$10.35M-14.35%
2009-09-30$12.09M-15.59%
2009-06-30$14.32M117.12%
2009-03-31$6.59M-43.33%
2008-12-31$11.63M-23.88%
2008-09-30$15.29M-18.09%
2008-06-30$18.66M-1.99%
2008-03-31$19.04M-8.63%
2007-12-31$20.84M-

BIOLASE generated $11.55M in revenue during Q2 2024, up 14.06% compared to the previous quarter, and up 110.39% compared to the same period a year ago.

BIOLASE Revenue Breakdown


BIOLASE Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Laser Systems$30.04M$31.44M$25.02M$12.34M$22.84M
Consumable And Other$13.60M$11.32M$9.46M$6.12M$7.16M
Service$5.53M$5.70M$4.71M$4.31M$7.16M
License Fees And Royalties----$12.00K
Imaging System----$619.00K

BIOLASE's latest annual revenue breakdown by segment (product or service), as of Dec 23: Laser Systems (61.11%), Consumable And Other (27.65%), and Service (11.24%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Consumable And Other$3.47M$3.54M$2.91M$4.12M$3.03M$2.94M$2.63M$3.04M$2.71M$2.53M$2.33M$2.36M$2.24M$1.86M$1.93M$862.00K$1.47M$1.49M$1.48M$2.08M
Service$1.49M$1.57M$1.37M$1.42M$1.17M$1.29M$2.08M$1.21M$1.12M$1.44M$1.12M$1.06M$981.00K$1.17M$898.00K$985.00K$1.26M$1.90M$1.99M$1.58M
Laser Systems$5.17M$8.38M$6.65M$8.75M$6.26M$9.82M$7.30M$7.99M$6.33M$8.44M$6.08M$5.72M$4.90M$5.49M$3.71M$1.09M$2.05M$6.79M$5.17M$4.92M
Imaging System--------------$4.00K$63.00K----
License Fees And Royalties-------------$3.00K$3.00K$3.00K----

BIOLASE's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Laser Systems (51.08%), Consumable And Other (34.24%), and Service (14.68%).

BIOLASE Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Non-US$15.28M$14.59M---
UNITED STATES$33.88M$33.88M$25.38M$16.20M$22.81M
Non Us--$13.80M$6.58M$14.98M

BIOLASE's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (68.92%), and Non-US (31.08%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
UNITED STATES$6.69M$9.09M$7.30M$10.74M$6.76M$9.59M$8.41M$8.90M$6.98M$8.36M$5.94M$5.87M$5.22M$6.12M$4.75M$2.19M$3.13M$5.85M$4.95M$5.90M
Non-US$3.44M$4.40M$3.62M$3.54M$3.71M$4.46M$3.60M$3.34M$3.19M$3.59M----------
Non Us---------$4.05M$3.27M$2.90M$2.40M$1.78M$743.00K$1.65M$4.33M$3.70M$2.75M-

BIOLASE's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (66.03%), and Non-US (33.97%).

BIOLASE Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
DXCMDexCom$3.62B$1.00B
TNDMTandem Diabetes Care$747.72M$331.03M
BVSBioventus$512.35M$151.22M
PACBPacific Biosciences of California$200.52M$38.81M
BIOLBIOLASE$49.16M$11.55M
HSCSHeart Test Laboratories$18.60M$14.70K
VVOSVivos Therapeutics$13.80M$4.05M
NNOXNano-X Imaging$9.90M$2.55M
NUWENuwellis$8.86M$2.19M
NAOVNanoVibronix$2.28M$817.00K
TIVCTivic Health Systems$1.18M$140.00K
TLISTalis Biomedical$412.00K-
BJDXBluejay Diagnostics--
BBLGBone Biologics--

BIOL Revenue FAQ


BIOLASE's yearly revenue for 2023 was $49.16M, representing an increase of 1.45% compared to 2022. The company's yearly revenue for 2022 was $48.46M, representing an increase of 23.67% compared to 2021. BIOL's yearly revenue for 2021 was $39.19M, representing an increase of 72.03% compared to 2020.

BIOLASE's quarterly revenue for Q2 2024 was $11.56M, a 14.06% increase from the previous quarter (Q1 2024), and a -19.12% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $10.13M, a -24.90% decrease from the previous quarter (Q4 2023), and a -3.21% decrease year-over-year (Q1 2023). BIOL's quarterly revenue for Q4 2023 was $13.49M, a 23.52% increase from the previous quarter (Q3 2023), and a -3.99% decrease year-over-year (Q4 2022).

BIOLASE's revenue growth rate for the last 3 years (2021-2023) was 25.46%, and for the last 5 years (2019-2023) was 30.07%.

BIOLASE's revenue streams in c 23 are Laser Systems, Consumable And Other, and Service. Laser Systems generated $30.04M in revenue, accounting 61.11% of the company's total revenue, down -4.45% year-over-year. Consumable And Other generated $13.6M in revenue, accounting 27.65% of the company's total revenue, up 20.08% year-over-year. Service generated $5.52M in revenue, accounting 11.24% of the company's total revenue, down -3.02% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of BIOLASE was Laser Systems. This segment made a revenue of $30.04M, representing 61.11% of the company's total revenue.